Notified Bodies, Authorized Reps And The CE Mark: How Does Post-Brexit Uncertainty Cloud Future MDR/IVDR?
This article was originally published in Clinica
Executive Summary
While the UK and the EU struggle to comprehend the full implications of the UK’s decision to leave the European Union, Amanda Maxwell considers the implications for the implementation of the future Medical Devices and IVD Regulations, including the question-mark that hangs over the future of UK notified bodies
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.